These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9406687)

  • 21. Implantation and growth of epidermal growth factor (EGF) receptor expressing human ovarian cancer xenografts in nude mice is dependent on EGF.
    Kurachi H; Morishige K; Adachi H; Adachi K; Tasaka K; Sawada M; Miyake A
    Cancer; 1994 Dec; 74(11):2984-90. PubMed ID: 7954262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antisense imaging of epidermal growth factor-induced p21(WAF-1/CIP-1) gene expression in MDA-MB-468 human breast cancer xenografts.
    Wang J; Chen P; Mrkobrada M; Hu M; Vallis KA; Reilly RM
    Eur J Nucl Med Mol Imaging; 2003 Sep; 30(9):1273-80. PubMed ID: 12640557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
    Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
    J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
    Raben D; Helfrich B; Chan DC; Ciardiello F; Zhao L; Franklin W; Barón AE; Zeng C; Johnson TK; Bunn PA
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):795-805. PubMed ID: 15701870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.
    Halmos G; Schally AV
    Proc Natl Acad Sci U S A; 1997 Feb; 94(3):956-60. PubMed ID: 9023364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photocytotoxic action of EGF-PVA-Sn(IV)chlorin e6 and EGF-dextran-Sn(IV)chlorin e6 internalizable conjugates on A431 cells.
    Gijsens A; De Witte P
    Int J Oncol; 1998 Dec; 13(6):1171-7. PubMed ID: 9824627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of human recombinant epidermal growth factor on the growth of MKN-28 human gastric carcinoma transplanted into nude mice.
    Murayama Y; Onishi Y; Mishima Y
    Eur J Cancer; 1992; 28A(12):1996-9. PubMed ID: 1329883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
    Ke S; Wen X; Gurfinkel M; Charnsangavej C; Wallace S; Sevick-Muraca EM; Li C
    Cancer Res; 2003 Nov; 63(22):7870-5. PubMed ID: 14633715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of EGF-dextran-tyrosine-131I conjugates on the clonogenic survival of cultured glioma cells.
    Andersson A; Capala J; Carlsson J
    J Neurooncol; 1992 Nov; 14(3):213-23. PubMed ID: 1281225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ha-ras induction of the invasive phenotype results in up-regulation of epidermal growth factor receptors and altered responsiveness to epidermal growth factor in human papillary transitional cell carcinoma cells.
    Theodorescu D; Cornil I; Sheehan C; Man MS; Kerbel RS
    Cancer Res; 1991 Aug; 51(16):4486-91. PubMed ID: 1868471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel, safe, fast and efficient treatment for Her2-positive and negative bladder cancer utilizing an EGF-anthrax toxin chimera.
    Jack S; Madhivanan K; Ramadesikan S; Subramanian S; Edwards DF; Elzey BD; Dhawan D; McCluskey A; Kischuk EM; Loftis AR; Truex N; Santos M; Lu M; Rabideau A; Pentelute B; Collier J; Kaimakliotis H; Koch M; Ratliff TL; Knapp DW; Aguilar RC
    Int J Cancer; 2020 Jan; 146(2):449-460. PubMed ID: 31584195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Balance between activated-STAT and MAP kinase regulates the growth of human bladder cell lines after treatment with epidermal growth factor.
    Kawamata H; Hattori K; Omotehara F; Uchida D; Hino S; Sato M; Oyasu R
    Int J Oncol; 1999 Oct; 15(4):661-7. PubMed ID: 10493946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conjugate chemistry, iodination and cellular binding of mEGF-dextran-tyrosine: preclinical tests in preparation for clinical trials.
    Zhao Q; Blomquist E; Bolander H; Gedda L; Hartvig P; Janson J; Lundqvist H; Mellstedt H; Nilsson S; Nistèr M; Sundin A; Tolmachev V; Westlin J; Carlsson J
    Int J Mol Med; 1998 Apr; 1(4):693-702. PubMed ID: 9852284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates.
    Razumienko EJ; Chen JC; Cai Z; Chan C; Reilly RM
    J Nucl Med; 2016 Mar; 57(3):444-52. PubMed ID: 26429962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor.
    Mellon JK; Cook S; Chambers P; Neal DE
    Br J Cancer; 1996 Mar; 73(5):654-8. PubMed ID: 8605103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal growth factor radiopharmaceuticals: 111In chelation, conjugation to a blood-brain barrier delivery vector via a biotin-polyethylene linker, pharmacokinetics, and in vivo imaging of experimental brain tumors.
    Kurihara A; Deguchi Y; Pardridge WM
    Bioconjug Chem; 1999; 10(3):502-11. PubMed ID: 10346884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted elastin-like polypeptide fusion protein for near-infrared imaging of human and canine urothelial carcinoma.
    Aayush A; Darji S; Dhawan D; Enstrom A; Broman MM; Idrees MT; Kaimakliotis H; Ratliff T; Knapp D; Thompson D
    Oncotarget; 2022; 13():1004-1016. PubMed ID: 36082359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancer.
    Mugabe C; Matsui Y; So AI; Gleave ME; Baker JH; Minchinton AI; Manisali I; Liggins R; Brooks DE; Burt HM
    Clin Cancer Res; 2011 May; 17(9):2788-98. PubMed ID: 21357680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ion exchange tumor targeting: a new approach.
    Holmberg AR; Wilchek M; Márquez M; Westlin JE; Du J; Nilsson S
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3056s-3058s. PubMed ID: 10541343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gefitinib enhances radiotherapeutic effects of
    Xia L; Peng H; Zhiqiang L; Xiaoli Z
    Nucl Med Biol; 2017 May; 48():63-68. PubMed ID: 28254656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.